IRF5 and cancer: Thus, the target proteins of the TRAF2/TRAF3 complex, namely, NF-kappaB-inducing kinase (NIK), c-Rel, and interferon regulatory factor 5 (IRF5), are activated, which upregulates inflammation-related genes and stemness-related genes in cancer cells [45].